Raynaud's Phenomenon: treatment of a severe case with biofeedback
Adair, J.R.; Theobald, D.E.
Journal of the Indiana State Medical Association 71(10): 990-993
1978
ISSN/ISBN: 0019-6770 PMID: 701835 Document Number: 133659
Document emailed within 1 workday
Related Documents
2000: Comparison of sustained-release nifedipine and temperature biofeedback for treatment of primary Raynaud phenomenon. Results from a randomized clinical trial with 1-year follow-up Archives of Internal Medicine 160(8): 1101-1108Lakshminarayanan, S.; Vázquez-Abad, D.; Maestrello, S.J.; Waterman, J.R. 1999: Treatment of severe Raynaud's phenomenon and ischemic ulcerations with tissue plasimogen activator Clinical and Experimental Rheumatology 17(2): 260
Neuhauser, B.; Perkmann, R.; Klingler, P.J.; Giacomuzzi, S.; Kofler, A.; Fraedrich, G. 2001: Clinical and objective data on spinal cord stimulation for the treatment of severe Raynaud's phenomenon American Surgeon 67(11): 1096-1097
Cuenca, R.; Fernández-Cortijo, J.; Lima, J.; Fonollosa, V.; Simeón, C.P.; Pico, M.; Soriano, B.; Vilardell, M. 1990: Platelet function study in primary Raynaud's phenomenon and Raynaud's phenomenon associated with scleroderma Medicina Clinica 95(20): 761-763
Di Biase, A. 2013: Mesoglycan treatment in Raynaud phenomenon: a case series Minerva Cardioangiologica 61(3): 323-331
Pratesi, F.; Corsi, C.; Deidda, C.; Nuti, A. 1976: Raynaud's phenomenon and Raynaud's disease definition of Raynaud's phenomenon Schweizerische Rundschau für Medizin Praxis 65(44): 1368-1370
Denton, C.P.; Howell, K.; Stratton, R.J.; Black, C.M. 2000: Long-term low molecular weight heparin therapy for severe Raynaud's phenomenon: a pilot study Clinical and Experimental Rheumatology 18(4): 499-502
Thulesius, O. 1979: Psychiatric treatment of Raynaud's phenomenon Lakartidningen 76(47): 4234
Bart, P.A.; Waeber, B. 2006: Understanding Raynaud's phenomenon: towards a better treatment Revue Medicale Suisse 2(48): 93-96
Delgado Daza, R.; Moga Donadeu, L.; Mañosa Bonamich, J.; Muncunill Gil, J.; Vidal Conde, V. 1991: Thoracic sympathectomy in the surgical treatment of Raynaud's phenomenon Angiologia 43(5): 180-182
Buryĭ, V.T.; Buryĭ, V.V. 2008: The treatment of neurospastic vascular diseases in Raynaud phenomenon Klinichna Khirurhiia 6: 36-39
Kahan, A.; Weber, S.; Amor, B.; Guerin, F.; Degeorges, M. 1983: Nifedipine in the treatment of migraine in patients with Raynaud's phenomenon New England Journal of Medicine 308(18): 1102-1103
Ota, M.; Shimizu, K.; Suzuki, T.; Yashima, G.; Asano, G.; Aihara, K. 1979: Peculiar vascular lesion and SLE syndrome with familial Raynaud phenomenon--an autopsy case Nihon Rinsho. Japanese Journal of Clinical Medicine 37(3): 646-648
Dowd, P.M.; Martin, M.F.; Cooke, E.D.; Bowcock, S.A.; Jones, R.; Dieppe, P.A.; Kirby, J.D. 1982: Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2) British Journal of Dermatology 106(1): 81-89
Piergiacomi, G.; Grassi, W.; Scendoni, P.; Caputi, A.; de Carolis, G.; Cervini, C. 1986: Association of carpal tunnel syndrome, Raynaud's phenomenon and cutaneous necrosis. Description of a clinical case Revue du Rhumatisme et des Maladies Osteo-Articulaires 53(6): 393-395
Belch, J.J.; Shaw, B.; O'Dowd, A.; Saniabadi, A.; Leiberman, P.; Sturrock, R.D.; Forbes, C.D. 1985: Evening primrose oil (Efamol) in the treatment of Raynaud's phenomenon: a double blind study Thrombosis and Haemostasis 54(2): 490-494
Zicot, M. 1980: Symptomatic treatment of Raynaud's phenomenon: reserpine, alpha-methyldopa, griseofulvin, guanethidine Revue Medicale de Liege 35(19): 652-654
Kyle, M.V.; Belcher, G.; Hazleman, B.L. 1992: Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenon Journal of Rheumatology 19(9): 1403-1406
Ranieri, G.; De Mitrio, V.; Petronelli, M.; Ancona, A.; Dammacco, F. 1988: Use of defibrotide in the treatment of Raynaud's phenomenon associated with progressive systemic sclerosis or essential mixed cryoglobulinemia La Clinica Terapeutica 126(5): 335-343
Lasfargues, G.; Royere, D.; Perrotin, D.; Titon, J.P.; Soutif, D.; Guilmot, J.L. 1987: Study of the plethysmographic amplification factor during vasodilator treatment. Healthy subject versus primary Raynaud phenomenon Journal des Maladies Vasculaires 12(4): 319-322